Milan criteria (MC) represents the cornerstone in the selection of patients with hepatocellular cancer (HCC) waiting for liver transplantation (LT). MC represent the precursor of the scores based on the idea of “utility”: in other terms, the scoring systems typically used in the field of LT oncology present the exclusive aim of selecting the cases with the best post-LT outcomes. However, some other scores have been proposed specifically investigating the risk of death or tumour progression during the waiting list. In this case, the selection process is connected with the idea of “priority”: patients at higher risk for drop-out (DO) should be selected, prioritising them or, conversely, deciding to de-list them due to the high risk of post-LT...
In addition to hepatitis C, hepatocellular carcinoma. is a leading indication for orthotopic liver t...
Ever since the initial description of the Milan criteria, used for selecting patients with hepatocel...
This prospective study analyzed the dropout probability and intention-to-treat survival rates of pat...
The Milan criteria (MC) remain the cornerstone for the selection of patients with hepatocellular can...
Liver transplantation (LT) for hepatocellular carcinoma (HCC) is strategically challenging because t...
Abstract: Liver transplantation (LT) offers excellent results for candidates with hepatocellular car...
Milan criteria are the most frequently used limits for liver transplantation (LT) in patients...
Simple Summary The ideal treatment for hepatocellular carcinoma (HCC) is liver transplantation (LT),...
Hepatocellular carcinoma (HCC) is the third highest cause of cancer-related mortality, and liver tra...
Hepatocellular carcinoma (HCC) is an aggressive cancer that occurs in the liver. It is the fifth mos...
When Milan criteria (MC) were first proposed in 1996, they rapidly became the cornerstone for the se...
The selection criteria in liver transplantation for HCC are a matter of debate. We reviewed our seri...
The current model of liver graft allocation in place in the United States favors transplantation of ...
This is the first systematic review assessing the valueof the MC as an independent prognostic factor...
Background: In the last several years, there has been no agreement on how to possibly expand the Mil...
In addition to hepatitis C, hepatocellular carcinoma. is a leading indication for orthotopic liver t...
Ever since the initial description of the Milan criteria, used for selecting patients with hepatocel...
This prospective study analyzed the dropout probability and intention-to-treat survival rates of pat...
The Milan criteria (MC) remain the cornerstone for the selection of patients with hepatocellular can...
Liver transplantation (LT) for hepatocellular carcinoma (HCC) is strategically challenging because t...
Abstract: Liver transplantation (LT) offers excellent results for candidates with hepatocellular car...
Milan criteria are the most frequently used limits for liver transplantation (LT) in patients...
Simple Summary The ideal treatment for hepatocellular carcinoma (HCC) is liver transplantation (LT),...
Hepatocellular carcinoma (HCC) is the third highest cause of cancer-related mortality, and liver tra...
Hepatocellular carcinoma (HCC) is an aggressive cancer that occurs in the liver. It is the fifth mos...
When Milan criteria (MC) were first proposed in 1996, they rapidly became the cornerstone for the se...
The selection criteria in liver transplantation for HCC are a matter of debate. We reviewed our seri...
The current model of liver graft allocation in place in the United States favors transplantation of ...
This is the first systematic review assessing the valueof the MC as an independent prognostic factor...
Background: In the last several years, there has been no agreement on how to possibly expand the Mil...
In addition to hepatitis C, hepatocellular carcinoma. is a leading indication for orthotopic liver t...
Ever since the initial description of the Milan criteria, used for selecting patients with hepatocel...
This prospective study analyzed the dropout probability and intention-to-treat survival rates of pat...